Investing Profile

Nilay Thakar

InvestorVC
Principal at ARCH Venture Partners
Photo of Nilay Thakar, Principal at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
CILA THERAPEUTICS Network
87 CONNECTIONS
cb
$50K - $150.0M
$25.0M
$635.8M
Co-Founder and Head of Business Development ARCH Stealth NewCoPresent
Board Observer Arbor BiotechnologiesPresent
Board Observer One BioMed Pte LtdPresent
Committee Member - Industry International Society for Stem Cell ResearchPresent
Board Member AgBiomePresent
Principal ARCH Venture PartnersPresent
General Manager - Stem Cells Ltd Australian Institute for Bioengineering and Nanotechnology AIBNPresent
Advisor - Theo Murphy High Flyers Think Tank The Australian Academy of SciencePresent
Commercialization Analyst Intern Dendright Pty LimitedPresent
Co-Founder and Head of BD ARCH Stealth NewCoPresent
Board Observer Lifordi ImmunotherapiesPresent
Board Observer SonoTheraPresent
Board Observer Volastra TherapeuticsPresent
Committee Member - Industry International Society for Stem Cell ResearchPresent
Co-Founder and Head of BD Skylark BioPresent
Board Observer Lifordi Immunotherapeutics, Inc.Present
Board Observer Doppler BioPresent
Board Observer hC Bioscience, Inc.Present
Board Observer CILA THERAPEUTICSPresent
The University of Queensland Bachelor of Science Honours Class 1 Biochemistry
The University of Queensland Doctor of Philosophy (Ph.D.) Stem Cell Biology